Cell-free microRNAs in Parkinson’s disease: potential biomarkers that provide new insights into disease pathogenesis
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are master post-transcriptional regulators of gene expression and their specific footprints reflect disease conditions. Over the last few years, several primary reports have described the deregulation of cell-free miRNAs in Parkinson's disease (PD), however, results have been rather inconsistent due to preanalytical and analytical challenges. This study integrated the data across twenty-four reports to identify steadily deregulated miRNAs that may assist in the path towards biomarker development and molecular characterization of the underlying pathology. Stringent KEGG pathway analysis of the miRNA targets revealed FoxO, Prolactin, TNF, and ErbB signaling pathways as the most significantly enriched categories while Gene Ontology analysis revealed that the protein targets are mostly associated with transcription. Chromosomal location of the consistently deregulated miRNAs revealed that over a third of them were clustered at the same location at Chr14q32 suggesting that they are co-regulated by specific transcription factors. This genomic region is inherently unstable due to expanded TGG repeats and responsible for human abnormalities. Stringent analysis of transcription factor sites surrounding the deregulated miRNAs revealed that CREB1, CEBPB and MAZ sites existed in approximately half of the miRNAs, including all of the miRNAs located at Chr14q32. Additional studies are now needed to determine the biomarker potential of the consistently deregulated miRNAs…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previously, several studies, yet not of a critical mass, have identified deregulated miRNAs in the different biofluids of PD patients. Generally, there is limited overlap between findings due to the source of biofluid used, sample size, methodology, and lack of appropriate controls. 13”
From Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients (2020) · cites this paper as [13]
In the citing paper
“Recently, we have integrated the data across 24 PD biomarker studies and identified 25 miRNAs reported deregulated in at least two studies. 13”
From Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients (2020) · cites this paper as [13]
Citations
Cites
Tackling the widespread and critical impact of batch effects in high-throughput data
Leek, J. T., Scharpf, R. B., Bravo, H. C., Simcha, D., Langmead, B., Johnson, W. E., Geman, D., Baggerly, K., & Irizarry, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2825 · Cited by 2,196
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
The clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
MicroRNA-mediated conversion of human fibroblasts to neurons
Yoo, A. S., Sun, A. X., Li, L., Shcheglovitov, A., Portmann, T., Li, Y., Lee-Messer, C., Dolmetsch, R. E., Tsien, R. W., & Crabtree, G. R. (2011) · Nature · doi:10.1038/nature10323 · Cited by 989
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Distribution of miRNA expression across human tissues
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw116 · Cited by 968
Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis
Rizzo, G., Copetti, M., Arcuti, S., Martino, D., Fontana, A., & Logroscino, G. (2016) · Neurology · doi:10.1212/wnl.0000000000002350 · Cited by 870
Research works printed but not linked: 116
- Abbas, 2018, Epidemiology of parkinson’s disease-east versus west, Mov. Disord. Clin. Pract., 5, 14, 10.1002/mdc3.12568 · DOI · Paper page
- Agarwal, 2015, Predicting effective microRNA target sites in mammalian mRNAs, eLife, 4
- Aloe, 1997, TNF-alpha expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior, Neurosci. Lett., 238, 65, 10.1016/S0304-3940(97)00850-1 · DOI
- Andersen, 2004, Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets, Cancer Res., 64, 5245, 10.1158/0008-5472.CAN-04-0496 · DOI · Paper page
- Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc. Natl. Acad. Sci. U.S.A., 108, 5003, 10.1073/pnas.1019055108 · DOI · Paper page
- Bai, 2017, Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease, Sci. Rep., 7, 5411, 10.1038/s41598-017-03887-3 · DOI · Paper page
- Bail, 2010, Differential regulation of microRNA stability, RNA, 16, 1032, 10.1261/rna.1851510 · DOI · Paper page
- Balcells, 2011, Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers, BMC Biotechnol., 11, 70, 10.1186/1472-6750-11-70 · DOI · Paper page
- Bellomo, 1991, Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson’s disease, J. Neurol., 238, 19, 10.1007/BF00319704 · DOI
- Bena, 2010, A recurrent 14q32.2 microdeletion mediated by expanded TGG repeats, Hum. Mol. Genet., 19, 1967, 10.1093/hmg/ddq075 · DOI · Paper page
- Bhidayasiri, 2017, Clinical assessments in parkinson’s disease: scales and monitoring, Int. Rev. Neurobiol., 132, 129, 10.1016/bs.irn.2017.01.001 · DOI
- Bielefeld, 2019, Co-administration of Anti microRNA-124 and -137 Oligonucleotides Prevents Hippocampal Neural Stem Cell Loss Upon Non-convulsive Seizures, Front. Mol. Neurosci., 12, 31, 10.3389/fnmol.2019.00031 · DOI
- Blondal, 2013, Assessing sample and miRNA profile quality in serum and plasma or other biofluids, Methods, 59, S1, 10.1016/j.ymeth.2012.09.015 · DOI · Paper page
- Boka, 1994, Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson’s disease, Neurosci. Lett., 172, 151, 10.1016/0304-3940(94)90684-X · DOI · Paper page
- Botta-Orfila, 2014, Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson’s disease, J. Neurosci. Res., 92, 1071, 10.1002/jnr.23377 · DOI · Paper page
- Buiting, 2008, Clinical features of maternal uniparental disomy 14 in patients with an epimutation and a deletion of the imprinted DLK1/GTL2 gene cluster, Hum. Mutat., 29, 1141, 10.1002/humu.20771 · DOI · Paper page
- Burgos, 2013, Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing, Rna, 19, 712, 10.1261/rna.036863.112 · DOI · Paper page
- Cao, 2018, Long noncoding RNA SNHG1 promotes neuroinflammation in parkinson’s disease via regulating miR-7/NLRP3 pathway, Neuroscience, 388, 118, 10.1016/j.neuroscience.2018.07.019 · DOI · Paper page
- Cardo, 2013, Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls, J. Neurol., 260, 1420, 10.1007/s00415-013-6900-8 · DOI · Paper page
- Carvey, 2005, Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat, J. Neural Transm., 112, 601, 10.1007/s00702-004-0222-z · DOI
- Chen, 2018, Planar cell polarity gene Fuz triggers apoptosis in neurodegenerative disease models, EMBO Rep., 19
- Cho, 2013, MicroRNA-205 regulates the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 protein, Hum. Mol. Genet., 22, 608, 10.1093/hmg/dds470 · DOI · Paper page
- Choi, 2014, MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA, J. Neurosci., 34, 12725, 10.1523/JNEUROSCI.0985-14.2014 · DOI · Paper page
- Choi, 2018, MicroRNA-7 facilitates the degradation of alpha-synuclein and its aggregates by promoting autophagy, Neurosci. Lett., 678, 118, 10.1016/j.neulet.2018.05.009 · DOI · Paper page
- Das, 1996, Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells, Oncogene, 13, 1139
- Ding, 2016, Identification of a panel of five serum miRNAs as a biomarker for Parkinson’s disease, Parkinsonism Relat. Disord., 22, 68, 10.1016/j.parkreldis.2015.11.014 · DOI · Paper page
- Doan, 2016, FoxO1 in dopaminergic neurons regulates energy homeostasis and targets tyrosine hydroxylase, Nat. Commun., 7, 12733, 10.1038/ncomms12733 · DOI · Paper page
- Dong, 2016, A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease, Biomarkers, 21, 129, 10.3109/1354750X.2015.1118544 · DOI · Paper page
- Dong, 2018, The neuroprotective role of MiR-124-3p in a 6-Hydroxydopamine-Induced cell model of parkinson’s disease via the regulation of ANAX5, J. Cell. Biochem., 119, 269, 10.1002/jcb.26170 · DOI · Paper page
- Dos Santos, 2018, miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease, Oncotarget, 9, 17455, 10.18632/oncotarget.24736 · DOI · Paper page
- Doxakis, 2010, Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153, J. Biol. Chem., 285, 12726, 10.1074/jbc.M109.086827 · DOI · Paper page
- Doxakis, 2013, Principles of miRNA-Target regulation in metazoan models, Int. J. Mol. Sci., 14, 16280, 10.3390/ijms140816280 · DOI
- Dumitriu, 2016, Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease, BMC Med. Genomics, 9, 5, 10.1186/s12920-016-0164-y · DOI · Paper page
- Eisler, 1981, Prolactin secretion in Parkinson disease, Neurology, 31, 1356, 10.1212/WNL.31.10.1356 · doi:10.1212/wnl.31.10.1356
- El-Khoury, 2016, Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material, Sci. Rep., 6, 19529, 10.1038/srep19529 · DOI · Paper page
- Fehlmann, 2016, Distribution of microRNA biomarker candidates in solid tissues and body fluids, RNA Biol., 13, 1084, 10.1080/15476286.2016.1234658 · DOI · Paper page
- Fragkouli, 2014, miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway, Front. Cell. Neurosci., 8, 182, 10.3389/fncel.2014.00182 · DOI · Paper page
- Gehrke, 2010, Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression, Nature, 466, 637, 10.1038/nature09191 · DOI · Paper page
- Geng, 2017, miR-124-3p attenuates MPP(+)-induced neuronal injury by targeting STAT3 in SH-SY5Y cells, Exp. Biol. Med., 242, 1757, 10.1177/1535370217734492 · DOI · Paper page
- Gong, 2016, miR-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK/mTOR pathway in Parkinson’s disease, Am. J. Transl. Res., 8, 2127
- Guo, 2014, Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues, Sci. Rep., 4, 5150, 10.1038/srep05150 · DOI · Paper page
- Hansen, 2016, Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome, Learn. Mem., 23, 61, 10.1101/lm.039578.115 · DOI · Paper page
- He, 2007, The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation, Neuron, 55, 217, 10.1016/j.neuron.2007.06.029 · DOI · Paper page
- Hermanson, 2003, Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells, Exp. Cell Res., 288, 324, 10.1016/S0014-4827(03)00216-7 · DOI · Paper page
- Hernandez-Rapp, 2015, Memory formation and retention are affected in adult miR-132/212 knockout mice, Behav. Brain Res., 287, 15, 10.1016/j.bbr.2015.03.032 · DOI · Paper page
- Hu, 2017, MiR-218 induces neuronal differentiation of ASCs in a temporally sequential manner with fibroblast growth factor by regulation of the wnt signaling pathway, Sci. Rep., 7, 39427, 10.1038/srep39427 · DOI
- Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
- Hunter, 2008, Detection of microRNA expression in human peripheral blood microvesicles, PLoS One, 3, e3694, 10.1371/journal.pone.0003694 · DOI · Paper page
- Iwakura, 2005, Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson’s disease and its model: neurotrophic implication in nigrostriatal neurons, J. Neurochem., 93, 974, 10.1111/j.1471-4159.2005.03073.x · DOI · Paper page
- Jiang, 2005, Age-dependent dopaminergic dysfunction in Nurr1 knockout mice, Exp. Neurol., 191, 154, 10.1016/j.expneurol.2004.08.035 · DOI
- Jin, 2018, Elevated microRNA-520d-5p in the serum of patients with Parkinson’s disease, possibly through regulation of cereloplasmin expression, Neurosci. Lett., 687, 88, 10.1016/j.neulet.2018.09.034 · DOI
- John, 2004, Human MicroRNA targets, PLoS Biol., 2, e363, 10.1371/journal.pbio.0020363 · DOI · Paper page
- Kanao, 2010, Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila, Hum. Mol. Genet., 19, 3747, 10.1093/hmg/ddq289 · DOI · Paper page
- Kelly, 1997, Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice, Neuron, 19, 103, 10.1016/S0896-6273(00)80351-7 · DOI · Paper page
- Khoo, 2012, Plasma-based circulating MicroRNA biomarkers for Parkinson’s disease, J. Parkinsons Dis., 2, 321, 10.3233/JPD-012144 · DOI · Paper page
- Kim, 2003, Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner, J. Neurochem., 85, 622, 10.1046/j.1471-4159.2003.01671.x · DOI · Paper page
- Klein, 2007, Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder, Neurology, 69, 2093, 10.1212/01.wnl.0000271880.27321.a7 · DOI · Paper page
- Knauss, 2018, Long noncoding RNA Sox2ot and transcription factor YY1 co-regulate the differentiation of cortical neural progenitors by repressing Sox2, Cell Death Dis., 9, 799, 10.1038/s41419-018-0840-2 · DOI
- Koh, 2012, Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant, J. Biol. Chem., 287, 12750, 10.1074/jbc.M111.337907 · DOI · Paper page
- Kruger, 2000, Genetic analysis of immunomodulating factors in sporadic Parkinson’s disease, J. Neural Transm., 107, 553, 10.1007/s007020070078 · DOI · Paper page
- Le, 1999, Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury, J. Neurochem., 73, 2218, 10.1046/j.1471-4159.1999.02218.x · DOI · Paper page
- Li, 2016, SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1alpha-mediated mitochondrial biogenesis, Oncotarget, 7, 29255, 10.18632/oncotarget.8711 · DOI
- Li, 2017, Plasma levels of miR-137 and miR-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depression, Neurol. Sci., 38, 761, 10.1007/s10072-017-2841-9 · DOI · Paper page
- Lim, 2005, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature, 433, 769, 10.1038/nature03315 · DOI · Paper page
- Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 · DOI · Paper page
- Ma, 2016, Serum miR-221 serves as a biomarker for Parkinson’s disease, Cell Biochem. Funct., 34, 511, 10.1002/cbf.3224 · DOI · Paper page
- McAlexander, 2013, Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid, Front. Genet., 4, 83, 10.3389/fgene.2013.00083 · DOI · Paper page
- McGeer, 1988, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains, Neurology, 38, 1285, 10.1212/WNL.38.8.1285 · DOI · Paper page
- McGuire, 2001, Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons, Exp. Neurol., 169, 219, 10.1006/exnr.2001.7688 · DOI · Paper page
- McMillan, 2017, Loss of MicroRNA-7 regulation leads to alpha-synuclein accumulation and dopaminergic neuronal loss in vivo, Mol. Ther., 25, 2404, 10.1016/j.ymthe.2017.08.017 · DOI · Paper page
- Miller, 2015, Biomarkers of Parkinson’s disease: present and future, Metab. Clin. Exp., 64, S40, 10.1016/j.metabol.2014.10.030 · DOI · Paper page
- Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U.S.A., 105, 10513, 10.1073/pnas.0804549105 · DOI · Paper page
- Mitchell, 2013, Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion, Acta Neuropathol., 125, 273, 10.1007/s00401-012-1043-z · DOI · Paper page
- Mogi, 2000, Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain, J. Neural Transm., 107, 335, 10.1007/s007020050028 · DOI · Paper page
- Mooney, 2015, High throughput qPCR expression profiling of circulating MicroRNAs reveals minimal sex- and sample timing-related variation in plasma of healthy volunteers, PLoS One, 10, 10.1371/journal.pone.0145316 · DOI · Paper page
- Mouradian, 2012, MicroRNAs in Parkinson’s disease, Neurobiol. Dis., 46, 279, 10.1016/j.nbd.2011.12.046 · DOI · Paper page
- Nishimura, 2001, Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson’s disease, Neurosci. Lett., 311, 1, 10.1016/S0304-3940(01)02111-5 · DOI
- Nitkowska, 2015, Prolactin and sex hormones levels in males with Parkinson’s disease, Acta Neurol. Scand., 131, 411, 10.1111/ane.12334 · DOI · Paper page
- Olejniczak, 2013, Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses, Proc. Natl. Acad. Sci. U.S.A., 110, 157, 10.1073/pnas.1219958110 · DOI · Paper page
- Paschou, 2012, Neurofibromin 1 is a miRNA target in neurons, PLoS One, 7, 10.1371/journal.pone.0046773 · DOI · Paper page
- Paschou, 2012, miRNA regulons associated with synaptic function, PLoS One, 7, 10.1371/journal.pone.0046189 · DOI · Paper page
- Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. U.S.A., 100, 8466, 10.1073/pnas.1032913100 · DOI · Paper page
- Pezet, 1997, The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor, Mol. Cell. Endocrinol., 129, 199, 10.1016/S0303-7207(97)00063-4 · DOI
- Pfaffl, 2004, Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--excel-based tool using pair-wise correlations, Biotechnol. Lett., 26, 509, 10.1023/B:BILE.0000019559.84305.47 · DOI · Paper page
- Postuma, 2015, MDS clinical diagnostic criteria for Parkinson’s disease, Mov. Disord., 30, 1591, 10.1002/mds.26424 · DOI · Paper page
- Ramon-Nunez, 2017, Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation, PLoS One, 12, 10.1371/journal.pone.0187005 · DOI
- Ravanidis, 2019, Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson’s disease, Mov. Disord.
- Sakurada, 1999, Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain, Development, 126, 4017, 10.1242/dev.126.18.4017 · DOI · Paper page
- Schaefer, 2008, Pituitary function and the somatotrophic system in patients with idiopathic Parkinson’s disease under chronic dopaminergic therapy, J. Neuroendocrinol., 20, 104, 10.1111/j.1365-2826.2007.01622.x · doi:10.1111/j.1365-2826.2007.01622.x
- Scherzer, 2008, GATA transcription factors directly regulate the Parkinson’s disease-linked gene alpha-synuclein, Proc. Natl. Acad. Sci. U.S.A., 105, 10907, 10.1073/pnas.0802437105 · DOI · Paper page
- Schimmel, 1999, 4.5 kb of the rat tyrosine hydroxylase 5’ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors, Brain Res. Mol. Brain Res., 74, 1, 10.1016/S0169-328X(99)00234-X · DOI
- Schouten, 2015, MicroRNA-124 and -137 cooperativity controls caspase-3 activity through BCL2L13 in hippocampal neural stem cells, Sci. Rep., 5, 12448, 10.1038/srep12448 · DOI · Paper page
- Scott, 2012, MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex, Eur. J. Neurosci., 36, 2941, 10.1111/j.1460-9568.2012.08220.x · DOI · Paper page
- Shen, 2014, Sphingosine 1-phosphate (S1P) promotes mitochondrial biogenesis in Hep G2 cells by activating Peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha), Cell Stress Chaperones, 19, 541, 10.1007/s12192-013-0480-5 · DOI
- Skirzewski, 2018, ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors, Mol. Psychiatry, 23, 2227, 10.1038/mp.2017.132 · DOI · Paper page
- St-Pierre, 2006, Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators, Cell, 127, 397, 10.1016/j.cell.2006.09.024 · DOI · Paper page
- Tan, 2013, MicroRNA-128 governs neuronal excitability and motor behavior in mice, Science, 342, 1254, 10.1126/science.1244193 · DOI · Paper page
- Tas, 2018, Parallel roles of transcription factors dFOXO and FER2 in the development and maintenance of dopaminergic neurons, PLoS Genet., 14, 10.1371/journal.pgen.1007271 · DOI
- Tysnes, 2017, Epidemiology of Parkinson’s disease, J. Neural Transm., 124, 901, 10.1007/s00702-017-1686-y · DOI · Paper page
- Valbuena, 2019, The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencing, Sci. Rep., 9, 15787, 10.1038/s41598-019-51948-6 · DOI · Paper page
- Vallelunga, 2014, Identification of circulating microRNAs for the differential diagnosis of Parkinson’s disease and Multiple System Atrophy, Front. Cell. Neurosci., 8, 156, 10.3389/fncel.2014.00156 · DOI · Paper page
- Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol., 3, 10.1186/gb-2002-3-7-research0034 · DOI · Paper page
- Wang, 2012, Comparing the MicroRNA spectrum between serum and plasma, PLoS One, 7
- Wang, 2019, MicroRNA-124 enhances dopamine receptor expression and neuronal proliferation in mouse models of parkinson’s disease via the hedgehog signaling pathway by targeting EDN2, Neuroimmunomodulation, 1
- Weishaupt, 2019, Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes, Bioinformatics, 35, 3357, 10.1093/bioinformatics/btz066 · DOI
- Wolfe, 2013, Visualizing genomic information across chromosomes with PhenoGram, BioData Min., 6, 18, 10.1186/1756-0381-6-18 · DOI · Paper page
- Wu, 2007, Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson’s disease, Am. J. Med. Genet. B Neuropsychiatr. Genet., 144B, 300, 10.1002/ajmg.b.30435 · DOI · Paper page
- Xu, 2011, JNK regulates FoxO-dependent autophagy in neurons, Genes Dev., 25, 310, 10.1101/gad.1984311 · DOI · Paper page
- Yamauchi, 1998, Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase, J. Biol. Chem., 273, 15719, 10.1074/jbc.273.25.15719 · DOI · Paper page
- Yang, 2012, miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression, J. Cell. Sci., 125, 1673
- Yang, 2019, Altered expression levels of MicroRNA-132 and Nurr1 in peripheral blood of parkinson’s disease: potential disease biomarkers, ACS Chem. Neurosci., 10, 2243, 10.1021/acschemneuro.8b00460 · DOI · Paper page
- Yao, 2018, MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson’s disease, J. Neuroinflammation, 15, 13, 10.1186/s12974-018-1053-4 · DOI · Paper page
- Yeri, 2018, Evaluation of commercially available small RNASeq library preparation kits using low input RNA, BMC Genomics, 19, 331, 10.1186/s12864-018-4726-6 · DOI · Paper page
- Zada, 2014, A rare, recurrent, de novo 14q32.2q32.31 microdeletion of 1.1 mb in a 20-Year-Old female patient with a maternal UPD(14)-Like phenotype and intellectual disability, Case reports in genetics, 2014, 10.1155/2014/530134 · DOI · Paper page
- Zetterstrom, 1997, Dopamine neuron agenesis in Nurr1-deficient mice, Science, 276, 248, 10.1126/science.276.5310.248 · DOI · Paper page
- Zhang, 2017, Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for parkinson’s disease, Front. Cell. Neurosci., 11, 170, 10.3389/fncel.2017.00170 · DOI · Paper page
Cited by
He, S., Huang, L., Shao, C., Nie, T., Xia, L., Cui, B., Lu, F., Zhu, L., Chen, B., & Yang, Q. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00249-y · Cited by 80
“ence from various components [27, 28], which calls for more applicable biomarkers for PD diagnosis.”
BackgroundValidation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
Ravanidis, S., Bougea, A., Papagiannakis, N., Koros, C., Simitsi, A. M., Pachi, I., Breza, M., Stefanis, L., & Doxakis, E. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51146 · Cited by 63
“3 used here], revealed that all top four GO categories controlled by the 25 deregulated miRNAs were likewise associated with transcription factors.(13) Hence, it appears that transcription factor misexpression is an important component of miRNA deregulation in PD.”
BackgroundSelf-citationProgress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
(2023) · doi:10.3390/pharmaceutics15082035 · Cited by 26
Metadata
- Authors
- Doxakis, E.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 58
- Pages
- 101023
- ISSN
- 1568-1637
- Cited by
- 22
- References
- 34
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell-free microRNAs in Parkinson’s disease: potential biomarkers that provide new insights into disease pathogenesis. https://app.cochat.ai/papers/10.1016/j.arr.2020.101023
- The paper
- Doxakis, E. (2020). Cell-free microRNAs in Parkinson’s disease: potential biomarkers that provide new insights into disease pathogenesis. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2020.101023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.